Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.04 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: vb-201, ic14 | 0.90 |
| trials ClinicalTrials.gov | 2 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 51 Parkinson's papers of 18,535 | 0.48 |
| pathways Reactome | 22 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 5585
Sealed predictions
- CD14 in dopamine neurons, braak+0.33 (p 0.389) → -0.30 (p 0.435)receipt 5592
Swarm cases
receipt 5592: CD14 in dopamine neurons, braak
- power
- full sample +0.11 (p 0.677, n 18), 95% CI -0.38 to +0.55. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.12 (p 0.646, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.12 (p 0.646, n 18). could be the mix.
- skeptic
- leave-one-out range +0.01 to +0.24, sign flips 0; without severely affected donors +0.11 (p 0.677, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CD14 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts